PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Results released for first multicenter study of hybrid revascularization

2013-03-10
(Press-News.org) The first multicenter study of hybrid revascularization shows that the emerging procedure for treating coronary artery disease has a similar rate of major adverse events in the first year, compared with percutaneous intervention (stenting).

Hybrid revascularization is a minimally invasive blend of coronary bypass surgery and stenting. It has been described as a "best of both worlds" strategy for treating multi-vessel coronary artery disease. Surgeons avoid opening the patient's sternum, which facilitates recovery, while keeping the durability of bypass surgery for the most important of the blocked coronary arteries.

John Puskas, MD, professor of surgery and associate chief of cardiothoracic surgery at Emory University School of Medicine, was national principal investigator for the study and is scheduled to present the results at the American College of Cardiology meeting in San Francisco.

Participating institutions included: Brigham and Women's, Columbia, Duke, Emory, Lankenau Hospital (Pennsylvania), Montefiore-Einstein Heart Center, Ohio State, University of Maryland, University of Pennsylvania, University of Virginia and Vanderbilt. The data coordinating center was housed in the Department of Health Evidence & Policy at the Icahn School of Medicine at Mount Sinai in New York. The study was funded by a Challenge grant – part of the 2009 American Recovery & Reinvestment Act – from the National Heart, Lung and Blood Institute, and was conducted in association with the NHLBI Cardiothoracic Surgery Trials Network.

The study was a prospective cohort study that enrolled 200 hybrid patients and 98 patients who would have been eligible for a hybrid procedure, but had multi-vessel percutaneous intervention (PCI) instead.

"We started by taking a snapshot of each participating center's catheterization lab over three months," Puskas says. "That was over 6,500 patients, but only a fraction were eligible. They had to have a pattern of coronary artery disease that could be reasonably treated with either hybrid techniques or multivessel percutaneous intervention: both an LAD (left anterior descending) lesion and a significant stenosis in at least one other non-LAD coronary artery. This was a group of patients with low to medium complexity coronary artery disease."

The primary measure of safety was the rate of major adverse coronary and cerebrovascular events (MACCE: includes death, heart attack, stroke or repeat revascularization procedure). Over the first year, hybrid patients had a MACCE rate of 11 percent (0.143 events per patient-year) while PCI patients had a rate of 10 percent (0.119 events per patient year), with hybrid revascularization displaying a trend toward a MACCE rate lower than PCI after the first year. Patients were followed for up to an average of 17.5 months and over that time, the MACCE rate for hybrid revascularization patients was 0.868 times that for PCI patients, adjusted for baseline risk.

"A question this study starts to address is, whether short-term outcomes and complications over the first year are comparable between these two alternative therapies," Puskas says. "These results suggest that hybrid revascularization is as safe in the first year, with a trend to benefit over the longer term. It would be a challenge to markedly out-perform PCI over the first year – we expect that if hybrid revascularization has an advantage, it will come out over the next few years."

He explains that multivessel coronary bypass surgery usually includes a left internal mammary artery (LIMA) graft for the blockage in the left anterior descending coronary artery (LAD), along with veins from the legs for the other blocked vessel(s). The LIMA graft has several advantages: most importantly, the LIMA graft stays open longer than vein grafts, because the LIMA is conditioned to higher blood pressures.

"We know the left internal mammary artery graft is the most durable treatment for that [LAD] blockage, so we expect there will be fewer repeat revascularizations in the hybrid group of patients," he says.

Hybrid revascularization keeps the LIMA graft for the LAD while using coronary stents for other non-LAD blockages, allowing a minimally invasive approach and avoiding use of the heart-lung machine.

"In light of the growing adoption of this treatment paradigm, a randomized trial of hybrid revascularization is now needed to rigorously evaluate its safety and efficacy relative to PCI," says Deborah D. Ascheim, MD, associate professor of health evidence & policy and cardiology at the Icahn School of Medicine at Mount Sinai, and principal investigator of the study's data coordinating center,

The results of the current study, Puskas agrees, support the Hybrid Observational Study Investigators' plans to conduct such a trial.

###

Co-author Michael Halkos, MD, assistant professor of surgery at Emory University School of Medicine, is giving a presentation Saturday, March 9 (6:45 pm ET), on the results of hybrid revascularization at Emory only.

2011 publication on hybrid revascularization and bypass surgery study at Emory: http://ats.ctsnetjournals.org/cgi/content/full/92/5/1695

END



ELSE PRESS RELEASES FROM THIS DATE:

Store donated blood for more than 3 weeks? Say NO (nitric oxide)

2013-03-10
Transfusion of donated blood more than three weeks old results in impaired blood vessel function, a new study of hospital patients shows. Blood banks now consider six weeks to be the maximum permitted storage time of blood for use in transfusion, but recent studies have suggested transfusing blood stored for more than a few weeks has adverse effects in patients undergoing cardiac surgery or critical care. The new finding suggests a mechanism explaining why older blood might be detrimental to patient health: a deficiency in nitric oxide, a short-lived chemical messenger ...

Researchers develop new tool to eliminate 30-day hospital readmissions in heart failure patients

2013-03-10
SALT LAKE CITY – Researchers at the Intermountain Heart Institute at Intermountain Medical Center have developed an innovative tool designed to eliminate 30-day hospital readmissions for heart failure patients and improve the quality of medical care a patient receives in the hospital. The tool, known as the IMRS-HF, was adapted from the Intermountain Risk Score (IMRS) that has been used at Intermountain Medical Center to predict mortality rates in trauma patients. Heart researchers discovered that by using the IMRS-HF, they could more accurately evaluate a patient's ...

Mortality for acute aortic dissection near 1 percent per hour during initial onset

2013-03-10
The belief among medical professionals in the 1950s that the mortality rate for type A acute aortic dissection during the initial 24 hours was one to two percent per hour appears to hold true in the contemporary era of treatment, based on a review of the large-scale IRAD registry being presented March 9 at the American College of Cardiology (ACC) Scientific Sessions. "In the 1950s, the medical literature suggested that the mortality rate for type A acute aortic dissection was one percent per hour, but we have limited information about the current rate in an era where ...

Beware: Newly recognized heart cardiomyopathy is not always benign

2013-03-10
Even though a newly recognized cardiomyopathy, which mainly impacts women, is typically treatable, Tako-tsubo cardiomyopathy can also be deadly when compounded by other co-morbidities, such as heart failure, according to a study being presented March 9 at the American College of Cardiology (ACC) Scientific Sessions. This condition, formally known as Tako-tsubo cardiomyopathy (TTC) and informally known as stress cardiomyopathy or broken heart syndrome, has abrupt onset of symptoms and is characterized by a distinctive left ventricular (LV) contraction profile. Ninety ...

Intermountain study finds length of DNA strands can predict life expectancy

2013-03-10
SAN FRANCISCO – Can the length of strands of DNA in patients with heart disease predict their life expectancy? Researchers from the Intermountain Heart Institute at Intermountain Medical Center in Salt Lake City, who studied the DNA of more that 3,500 patients with heart disease, say yes it can. In the new study, presented Saturday, March 9, at the American College of Cardiology's Annual Scientific Session in San Francisco, the researchers were able to predict survival rates among patients with heart disease based on the length of strands of DNA found on the ends ...

Mayo Clinic study finds electric car does not interfere with implanted cardiac devices

2013-03-10
PHOENIX – A Mayo Clinic study has concluded that patients with implanted cardiac devices such as pacemakers and defibrillators can safely drive or ride in an electric car without risk of electromagnetic interference (EMI). The study, titled "Hybrid Cars and Implantable Cardioverter Defibrillators: Is It Safe?" is the first of its kind to address the interaction between these devices and electric cars. It will be presented at the 2013 American College of Cardiology Annual Scientific Session in San Francisco on March 9. In some cases, implanted devices may sense signals ...

Mark Denker MD Offers Innovative Implantation Failure Test

2013-03-10
Palm Beach Fertility Center founder Mark Denker MD says new test may help to determine and treat IVF implantation failure cause. Mark Denker MD recently announced that a new test is available to IVF patients experiencing implantation failure. Palm Beach Fertility CenterâEUR s Mark Denker MD offers the test on-site at the Center and reports that it is designed to monitor the endometrium during the time of implantation. According to Mark Denker MD, this allows physicians the opportunity to get to the bottom of IVF failure in otherwise healthy women. According to Mark ...

Features of Teardrop Banners

2013-03-10
As the name suggests, teardrop banners look like dropping tears and these are special type of marketing equipment that can offer reusability and portability features to businesses. Among the different mediums available for marketing, this is considered cost effective and it is also known to offer the best value for the money spent by the entrepreneurs. It is known to increase the level of exposure available to businesses and whenever this marketing means is used, businesses can get the attention of prospective customers. They can be used in places where people gather in ...

Future Problem Solving Program International Announces Topic on International Women's Day

2013-03-10
A Chinese saying, "Women hold up half the sky," was the inspiration for The Future Problem Solving Program International's selection of this year's topic to be used at their International Conference. FPSPI, an educational non-profit competition for students ages 10 and beyond, is announcing its topic for the International Conference on International Women's Day this year. International Women's Day was first observed in 1909, and in 1981 Congress established National Women's History Week to be commemorated the second week of March. Congress later expanded the week ...

Paranormal Insider Radio to Interview Medium/Author/Scientist Rob Gutro

2013-03-10
Paranormal Insider Radio, associated with the paranormal group featured on A&E Television's "Paranormal State" will be interviewing medium and scientist Rob Gutro about his newest book, "Lessons Learned from Talking to the Dead," on Monday, March 11 at 9 p.m. ET. The radio program is broadcast free over the Internet. Join host, Alex Matsuo, as she interviews meteorologist, Rob Gutro. The special thing about Rob is that not only is he a meteorologist, but he is also a medium. How does he balance his scientific knowledge with his abilities and ...

LAST 30 PRESS RELEASES:

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

Mission accomplished for the “T2T” Hong Kong Bauhinia Genome Project

[Press-News.org] Results released for first multicenter study of hybrid revascularization